Latest Capital Deployment News

Page 5 of 37
Key Petroleum Ltd has wrapped up the last 3% tranche of its share placement, raising nearly $59,000 and exhausting its 15% ASX placement limit. The fresh capital is earmarked for asset acquisitions, development, and working capital.
Maxwell Dee
Maxwell Dee
1 May 2026
Epsilon Healthcare has achieved its highest quarterly receipts ever with $3.14 million in Q1 2026, driven by strong expansion across contract manufacturing, clinics, and pharmacy operations.
Ada Torres
Ada Torres
30 Apr 2026
Livium Ltd boosted battery recycling revenue and secured a new centralised hub to expand capacity, while advancing rare earth and solar panel recycling technologies. Strategic funding for its lithium cathode plant remains under review.
Victor Sage
Victor Sage
30 Apr 2026
Liontown Limited has kicked off early works and long-lead procurement for its Kathleen Valley lithium expansion, ahead of a Final Investment Decision expected by March 2027.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Brightstar Resources (ASX:BTR) has fully funded its Goldfields Project development with a $193 million equity raise and a US$120 million senior secured bond, targeting 75,000oz gold production from mid-2027 while progressing Sandstone towards a Final Investment Decision.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Australis Oil & Gas has partnered with a major US-listed company to develop its Tuscaloosa Marine Shale assets, retaining a 10% interest in producing wells and holding a strong cash position after recent transactions.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Predictive Discovery Limited (ASX:PDI) completed its merger with Robex Resources, propelling gold production to 48,178 ounces in Q1 2026 and setting sights on 400,000 ounces annual production by 2029.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Castile Resources has kicked off pilot plant bench scale testing for its Rover 1 project, integrating a 41% resource upgrade and higher metal prices into its Bankable Feasibility Study. The company also secured $8.4 million in funding and is preparing for exploration drilling amid regional consolidation.
Maxwell Dee
Maxwell Dee
27 Apr 2026
PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.
Ada Torres
Ada Torres
27 Apr 2026
Megaport’s Latitude.sh has secured a $35.4 million three-year compute and storage deal, adding nearly $12 million in annual recurring revenue and underpinning the company’s growth in AI-driven infrastructure.
Sophie Babbage
Sophie Babbage
27 Apr 2026
DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.
Claire Turing
Claire Turing
23 Apr 2026
Adisyn Ltd has landed a A$14 million placement led by heavyweight institutional investors following two major graphene technology milestones in semiconductors and stealth drone materials.
Sophie Babbage
Sophie Babbage
23 Apr 2026